MariMed Inc (OTCPK:MRMD)

Q3 2025 MariMed Inc Earnings Call Transcript

Nov 6, 2025 / 01:00 PM GMT

Release Date Price: $0.097 (-12.53%)

Transcript 10-Q8-K

Key Points

Positve

MariMed Inc (MRMD) reported sequential growth in both wholesale and retail revenue, along with an increase in EBITDA and positive cash flow from operations.
The company achieved a 23% increase in sales in Illinois and a 5% increase in Massachusetts, despite statewide sales declines, showcasing the strength of their brands.
MariMed Inc (MRMD) successfully launched adult-use sales in Delaware, resulting in a 48% sequential increase in retail revenue.
The company is expanding its brand distribution through strategic licensing partnerships and M&A, with a focus on high-growth states like Pennsylvania and New York.
MariMed Inc (MRMD) is entering the hemp market, with plans to launch a hemp-based THC product, Vibations, in Rhode Island, leveraging partnerships with industry leaders.

Negative

The company faces ongoing industry challenges such as price pressure, retail oversaturation, and lack of clarity on federal rescheduling.
Retail revenue saw a 3% year-over-year decline, primarily due to reduced performance at the Metropolis dispensary in Illinois.
Non-GAAP adjusted gross margin decreased by 400 basis points quarter-over-quarter, impacted by the shift in revenue mix towards wholesale.
MariMed Inc (MRMD) exited the Missouri market due to insufficient cash flow, indicating challenges in certain regional markets.
The company reported a net loss of $2.9 million for the quarter, an increase from the previous quarter and the same period last year, due to higher income tax expenses.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MRMD.PK - Marimed Inc
Q3 2025 MariMed Inc Earnings Call
Nov 06, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. My name is Jordan, and I'll be assigned. The conference operator today. At this time, I'd like to welcome everyone to the Merrimed Inc. 3rd quarter 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you'd like to ask a question during this time, simply press star and then the number 1 on your telephone keypad. If you'd like to withdraw your question, Please press pound key followed by the number 1.

Thank you. I would now like to turn the call over to Mr. Howard Sattcher, Chief Communications Officer, to begin the conference.

-----------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.